Biotech

All Articles

ArsenalBio elevates $325M, rotates far from past lead property

.Toolbox Biosciences is carrying on up. The cell treatment firm has actually added $325 million in a...

Lilly- supported fat loss biotech data IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has submitted...

Aelis' marijuana make use of medication flunks period 2b, steering Indivior to rethink $100M choice

.Aelis Farma's chances of protecting an easy, beneficial decision on a $100 million possibility sett...

ProKidney standstills stage 3 test certainly not needed to have for tissue treatment confirmation

.ProKidney has stopped one of a set of period 3 trials for its cell therapy for kidney illness after...

Vaxcyte rises on 'magnificent' 31-valent PCV succeed versus Pfizer

.Vaxcyte revealed what professionals referred to as "magnificent" stage 1/2 information for its own ...

Recursion's brain ailment trial reveals insufficient proof of effectiveness

.Recursion has actually stumbled by means of an early examination of its tech-enabled technique to m...

Acepodia, Pfizer click on together for chemistry-based tissue treatment

.Phone it a scenario of excellent chemical make up: Acepodia, a biotech based upon Nobel Prize-winni...

Praxis epilepsy drug minimizes seizures in period 2 litigation

.Praxis Accuracy Medicines has actually scored one more midphase win in epilepsy this year, along wi...

Three officers resign as Dyne blog posts mixed records for DMD prospect

.After running away a medical grip a number of years back, Dyne Rehab has actually uncovered brand n...

Arrowhead fires off stage 3 information in uncommon metabolic ailment in front of market encounter Ionis

.Arrowhead Pharmaceuticals has actually revealed its hand ahead of a possible showdown along with Io...